Ownership Summary
Quarter ending 30 Jun, 2026
Ascentage Pharma Group International (NASDAQ:AAPG) showed up in the 13F filings of 8 institutional investors as of June 2026.
- They owned 0.0% of outstanding stock in June 2026, down from 0.0% the prior quarter.
- They decreased total shares held in Ascentage Pharma Group International by -10.4% from last quarter, and the number of investors in AAPG decreased 33.33% annually.
- Of these 8 funds, 4 grew their exposure to Ascentage Pharma Group International, 3 cut back, and 1 maintained positions.
- In total, institutional investors held 15.01K shares in Ascentage Pharma Group International as of June 2026, down by 1.74K shares quarter on quarter, and down 65.82K shares year over year.
- Point72 Asset Management, L.P. holds the largest position in AAPG at 13.84K shares as of June 30, 2026, or 0.02% of shares outstanding.
- Top purchasers of AAPG stock for the quarter ending June 2026 included Morgan Stanley (421), Wells Fargo & Company/Mn (200), BlackRock, Inc. (6), Caitong International Asset Management Co., Ltd (1).
- The largest sellers of Ascentage Pharma Group International for the quarter ending June 2026 were Point72 Asset Management, L.P. (2.22K), UBS Group AG (109), EverSource Wealth Advisors, LLC (47).
- Business Quant data shows the 8 biggest positions in Ascentage Pharma Group International as of June 2026 are held by Point72 Asset Management, L.P. (13.84K), Morgan Stanley (919), Wells Fargo & Company/Mn (200), EverSource Wealth Advisors, LLC (24), UBS Group AG (15), Royal Bank Of Canada (6), BlackRock, Inc. (6), Caitong International Asset Management Co., Ltd (1).